These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 11504274

  • 1. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
    Oh JM, Wiland AM, Klassen DK, Weidle PJ, Bartlett ST.
    J Clin Pharmacol; 2001 Aug; 41(8):861-9. PubMed ID: 11504274
    [Abstract] [Full Text] [Related]

  • 2. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM, Henry ML, Melzer JS, Sollinger HW, Sutherland DE, Taylor RJ.
    Transplantation; 2000 Jul 15; 70(1):105-11. PubMed ID: 10919583
    [Abstract] [Full Text] [Related]

  • 3. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.
    Transplantation; 1998 Dec 27; 66(12):1751-9. PubMed ID: 9884272
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M, Earley AK, Webster AC, Schmid CH, Balk EM, Uhlig K.
    Cochrane Database Syst Rev; 2015 Dec 03; 2015(12):CD007746. PubMed ID: 26633102
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 03; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 11. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL, Pearson TC, Odom KL, Larsen CP.
    Clin Transplant; 2000 Aug 03; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [Abstract] [Full Text] [Related]

  • 12. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
    Palmer SM, Baz MA, Sanders L, Miralles AP, Lawrence CM, Rea JB, Zander DS, Edwards LJ, Staples ED, Tapson VF, Davis RD.
    Transplantation; 2001 Jun 27; 71(12):1772-6. PubMed ID: 11455257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience.
    Rigotti P, Cadrobbi R, Baldan N, Sarzo G, Parise P, Furian L, Marchini F, Ancona E.
    Clin Nephrol; 2000 Apr 27; 53(4):suppl 52-4. PubMed ID: 10809437
    [Abstract] [Full Text] [Related]

  • 15. Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation.
    Zuckermann A, Klepetko W, Birsan T, Taghavi S, Artemiou O, Wisser W, Dekan G, Wolner E.
    J Heart Lung Transplant; 1999 May 27; 18(5):432-40. PubMed ID: 10363687
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.
    Ann Transplant; 2000 Dec 27; 5(1):43-6. PubMed ID: 10850611
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.